الفهرس | Only 14 pages are availabe for public view |
Abstract Exposure to toxic substance can affect the body in many ways.in general, when chemicals and other toxic substances are absorbed, they travel through the various body systems and can affect a particular organs, called the target organs. the body has mechanisms, mainly in the liver and kidneys, to process and eliminate many of these substances. Liver diseases: Liver has important functions in the body, including detoxification, plasma protein synthesis and glycogen storage (Yang et al., 2011). Because of its unique metabolism and relationship to the gastrointestinal tract, the liver is a crucial target of the toxicity of drugs, xenobiotics and oxidative stress (Jaeschke et al., 2002). Liver is the key organ of metabolism and excretion so it is continuously and variedly exposed to xenobiotics because of its strategic placement in the body (Shaker et al., 2010). Evidences developed over the last several years have suggested that various forms of liver injury may be caused by free radical formation and subsequent oxidative stress (Bhadauria et al., 2008). Also Loguercio and Federico (2003) stated that all processes that involve hepatocyte, Kupffer, stellate and endothelial cells which induce liver disease are related to the crucial role of reactive oxygen and nitrogen species. It is believed that reactive oxygen species (ROSs), such as hydroxyl radical, super oxide radical anion and nitric oxide may injure cell membranes through lipid peroxidation and damage biomolecules, i.e., proteins, lipids, carbohydrates and DNA in vitro and in vivo (Halliwell, 1996 and Graziewicz et al., 2002). Documented evidence has been reported that reactive oxygen species (ROSs), including singlet oxygen, super oxide and hydroxyl radicals are knownto play an important role in liver-disease pathology and progression (Vitaglione et al., 2004). Significant cellular damage occurs when the amount of produced free radicals exceeds the capacity of endogenous cellular antioxidant defense system. The main sources of free radicals are represented by hepatocyte mitochondria and cytochrome P450 enzymes, by endotoxinactivated macrophages (Kupffer cells) and by neutrophils. In chronic liver injury, the injured cells release a number of cytokines (Tipoe et al., 2010). These cytokines then stimulate the Kupffer cells to release more inflammatory mediators and various free radicals (Clària et al., 2011). The presence of high concentration of these pro-inflammatory mediators and free radicals then activities a large number of neutrophils to release pro-inflammatory mediators and free radicals (Makni et al., 2011). One of sources of generation of reactive oxygen species (ROSs) is CCl4. Carbon tetrachloride (CCl4) is frequently used to produce liver injury in animals so it is used to evaluate the therapeutic potential of drugs (Basu, 2011). CCl4 is responsible for oxidative stress and lipid peroxidation through cytochrome P450-mediated generation of highly reactive radicals, leading to eventual damage characterized by hepatocellular necrosis (Gong et al., 2012). Liver diseases often progress from sub-clinical icteric hepatitis to necro-inflammatory hepatitis, fibrosis, cirrhosis and hepatocellular carcinoma (Vitaglione et al., 2004 and Cristovao et al., 2007). Liverfibrosis is characterized by excessive accumulation of extracellular matrix (ECM) proteins such as type I and type IV collagen within the perisinusoidal space of Disse (Dai et al., 2009). It is a major feature of most chronic liver injuries, including metabolic, viral, cholestatic and biliary disorders (Pinzani and Rombouts, 2004; Haber et al., 2008 and Henderson and Forbes, 2008). Abnormal flow of bile acids and bilirubin in the liver is characterized of cholestasis, which leads to retention and accumulation of toxic hydrophobic bile salts within hepatocytes (Faubion et al., 1999), causing inflammatory reactions, hepatocyte death and periductular fibrosis (Webster and Anwer, 1998). Oxidative stress is likely to play a key role in cholestasisinduced liver fibrosis, as evidenced by reduced liver injury and fibrosis after bile duct ligation (BDL) in mice lacking NADPH oxidase (NOX- 1), which produces reactive oxygen species (ROSs) (Cui et al., 2011). The cirrhosis of liver is a heterogeneous group of chronic, progressive and irreversible diseases for which no satisfactory treatment is available (Conn, 1975). All cases of cirrhosis are characterized morphologically by the loss of normal liver architecture, which is replaced by a new tridimensional structure based on the combination of variable degrees of liver cell regeneration and excessive connective tissue deposition (Popper, 1977). Cirrhosis produces hepatocellular dysfunction and increased intra-hepatic resistance to blood flow, which result in hepatic insufficiency and portalhypertension, respectively (Gines et al., 2004). Cirrhosis affects hundreds of millions of patients world wide. Modern medicines have little to offer for attenuation of hepatic diseases and it is chiefly the plant based preparations which are employed for the treatment of liver disorders (Somasundaram et al., 2010). There is a great demand for the development of an efficient hepatoprotective drug from the natural resources (Tandon et al., 2008). Plants are rich source of bioactive components that have desirable health benefits and are traditionally known to be useful for prevention of chronic diseases. Many studies have reported that antioxidant supplements are effective in preventing oxidative-stress-related liver pathologies due to particular interactions and synergisms (Bhathal et al., 1983 and Vitaglione et al., 2004). Kidney diseases: Kidney is a paired organ whose functions include removing waste products from the blood and regulating the amount of fluid in the body. The basic units of the kidney are microscopically thin structures called nephrons, which filter the blood and cause wastes to be removed in the form of urine. Together with the bladder, two ureters, the single urethra and the kidneys make up the body’s urinary system. Acute renal failure occurs frequently in critically ill patients in intensive care (Nissenson, 1998). This disorder is defined as a sudden |